Lower dose of common antibiotic can treat rare hair loss condition
- Low doses of antibiotics can effectively treat lymphocytic scarring alopecia with fewer side effects than higher doses, according to researchers at NYU Langone Health.
- Only 12% of patients on lower doses experienced side effects, compared to 23% on higher doses, reflecting better tolerability.
- The study involved 241 patients and found no significant difference between low and high doses in treating hair loss and inflammation.
- The findings indicate that using lower doses may help reduce adverse reactions and the risk of antibiotic resistance, promoting better gut health.
99 Articles
99 Articles
Low doses of antibiotic work just as well as higher ones to treat rare type of chronic hair loss
Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows. This regimen may also come with fewer side effects than higher doses of the medication.

Rare Hair Loss Condition Can Be Treated With Low Doses Of Antibiotic
Key Takeaways

Low Doses of Antibiotic Work Just as Well as Higher Ones to Treat Rare Type of Chronic Hair Loss
NEW YORK, March 18, 2025 /PRNewswire/ -- Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows. This regimen may also come…
Eating celery may stop hair from going grey
Luteolin — a natural flavonoid found in various fruits, vegetables, and herbs — has been found to slow the process of greying hair. Researchers from Nagoya University in Japan found that it helps maintain the proper function of melanocytes, which are cells that produce hair pigment that gives hair its colour. The scientists conducted the study over 16 weeks on a set of mice, who had been genetically modified to develop grey hair prematurely. …
Coverage Details
Bias Distribution
- 63% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage